Shipp MA - Search Results

1

Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma.

Ouyang J, Plütschow A, Pogge von Strandmann E, Reiners KS, Ponader S, Rabinovich GA, Neuberg D, Engert A, Shipp MA. Ouyang J, et al. Among authors: shipp ma. Blood. 2013 Apr 25;121(17):3431-3. doi: 10.1182/blood-2012-12-474569. Epub 2013 Feb 26. Blood. 2013. PMID: 23444403 Free article.

2

Prognostic factors in non-Hodgkin's lymphoma.

Shipp M. Shipp M. Curr Opin Oncol. 1992 Oct;4(5):856-62. doi: 10.1097/00001622-199210000-00007. Curr Opin Oncol. 1992. PMID: 1457500 Review.

3

Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies.

Salles G, Zain M, Jiang WM, Boussiotis VA, Shipp MA. Salles G, et al. Among authors: shipp ma. Blood. 1993 Dec 15;82(12):3539-47. Blood. 1993. PMID: 7505117 Free article.

4

Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?

Shipp MA. Shipp MA. Blood. 1994 Mar 1;83(5):1165-73. Blood. 1994. PMID: 8118021 Free article. Review.

5

High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study.

Shipp MA, Neuberg D, Janicek M, Canellos GP, Shulman LN. Shipp MA, et al. J Clin Oncol. 1995 Dec;13(12):2916-23. doi: 10.1200/JCO.1995.13.12.2916. J Clin Oncol. 1995. PMID: 8523055

6

CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src-related kinase.

Ganju RK, Shpektor RG, Brenner DG, Shipp MA. Ganju RK, et al. Among authors: shipp ma. Blood. 1996 Dec 1;88(11):4159-65. Blood. 1996. PMID: 8943850 Free article.

7

Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.

Janicek M, Kaplan W, Neuberg D, Canellos GP, Shulman LN, Shipp MA. Janicek M, et al. Among authors: shipp ma. J Clin Oncol. 1997 Apr;15(4):1631-7. doi: 10.1200/JCO.1997.15.4.1631. J Clin Oncol. 1997. PMID: 9193363

8

A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma.

Yakushijin Y, Steckel J, Kharbanda S, Hasserjian R, Neuberg D, Jiang W, Anderson I, Shipp MA. Yakushijin Y, et al. Among authors: shipp ma. Blood. 1998 Jun 1;91(11):4282-91. Blood. 1998. PMID: 9596677 Free article.

9

PTPROt: an alternatively spliced and developmentally regulated B-lymphoid phosphatase that promotes G0/G1 arrest.

Aguiar RC, Yakushijin Y, Kharbanda S, Tiwari S, Freeman GJ, Shipp MA. Aguiar RC, et al. Among authors: shipp ma. Blood. 1999 Oct 1;94(7):2403-13. Blood. 1999. PMID: 10498613 Free article.

10

BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration.

Aguiar RC, Yakushijin Y, Kharbanda S, Salgia R, Fletcher JA, Shipp MA. Aguiar RC, et al. Among authors: shipp ma. Blood. 2000 Dec 15;96(13):4328-34. Blood. 2000. PMID: 11110709 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters